July 5, 2006

Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking CessationA Randomized Controlled Trial

Key points are not available for this paper at this time.

clinicaltrials.gov Identifier: NCT00141206.

Bookmark

Cite This Study

David Gonzales (Wed,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark